Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysis
Schizophrenia Bulletin · 10.04.2026 · 52 (3)
DOI: 10.1093/schbul/sbag069 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Schizophrenia Bulletin, online erschienen am 11.05.2026. Verfasst von Jack B Fanshawe und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom. Hauptthemen laut MEDLINE: Choline, Psychotic Disorders, Proton Magnetic Resonance Spectroscopy, Prefrontal Cortex. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust Clinical Research Career Development Fellowship, NIHR Oxford Health Biomedical Research Centre, NIHR or the Department of Health and Social Care.
Abstract (Originalsprache)
Background and Hypothesis Animal, post-mortem, and pharmacological studies suggest altered choline levels in psychosis. Proton magnetic resonance spectroscopy (1H-MRS) may allow in vivo investigation of the cholinergic system. This meta-analysis examined the magnitude and variability of 1H-MRS choline across the psychosis spectrum. Study Design Following a pre-registered protocol (CRD42023403879), we searched MEDLINE, EMBASE, and PsycINFO for studies reporting 1H-MRS choline levels in individuals with psychosis, clinical high risk (CHR) states, and healthy controls. Standardized mean differences (SMDs) and log coefficient of variation ratios were pooled using random-effects meta-analysis, stratified by brain region and clinical subgroup. Meta-regression examined associations with imaging and clinical parameters. Study Results We included 165 studies comprising 5178 patients and 4269 controls. Choline levels were elevated in people with psychosis in the anterior cingulate cortex (ACC: SMD = 0.23, CI 0.12–0.33), medial prefrontal cortex (mPFC: SMD = 0.12, CI 0.01-0.23), and dorsolateral prefrontal cortex (dlPFC: SMD = 0.15, CI 0.01-0.28). Elevations were also seen in CHR cohorts (ACC: SMD 0.19, CI 0.03-0.36; mPFC: SMD 0.36, CI 0.16-0.57), with the largest effects in treatment-resistant schizophrenia (ACC: SMD 0.65, CI 0.38-0.91; dlPFC: SMD 1.13, CI 0.65-1.60). Increased choline variability was observed in the dlPFC in psychosis cohorts and the mPFC and temporal lobe in CHR groups. Conclusions This is the largest meta-analysis of 1H-MRS choline in psychosis to date. Increased variability in psychosis and greater differences in treatment-resistant cohorts suggest increased choline levels might identify a subgroup who do not respond to dopamine antagonist treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom.
- TUNE-UP service, Oxford Health NHS Foundation Trust, Oxford OX3 7JX, United Kingdom.
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.
- Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.
- South London and Maudsley NHS Foundation Trust, London SE5 8AZ, United Kingdom.
- Wellcome Centre for Integrative Neuroimaging (WIN) & MRC Brain Network Dynamics Unit (BNDU), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom.
ORCID-Profile: Cameron J Watson, Doğukan Koçyiğit, Toby Pillinger
Förderung
- Wellcome Trust Clinical Research Career Development Fellowship
- NIHR Oxford Health Biomedical Research Centre
- NIHR or the Department of Health and Social Care
- UKRI MRC Clinical Research Training Fellowship
- NIHR Academic Clinical Fellowship
- NIHR Maudsley Biomedical Centre Predoctoral Fellowship
- SNSF Post-Doctoral Mobility Fellowship
- UK National Institute for Health Research (NIHR)
Zitieren
APA
Fanshawe, J. B., Watson, C. J., Mancini, V., Cohen, M., Koçyiğit, D., Bohra, R., Zauchenberger, C. Z., Varvari, I., Farid, A., Perez-Rodriguez, V., Gifford, G., Pillinger, T., Beck, K., Jauhar, S., McGuire, P., & McCutcheon, R. A. (2026). Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysis. Schizophrenia Bulletin, 52(3). https://doi.org/10.1093/schbul/sbag069
Vancouver
Fanshawe JB, Watson CJ, Mancini V, Cohen M, Koçyiğit D, Bohra R, et al. Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysis. Schizophrenia Bulletin. 2026;52(3). doi:10.1093/schbul/sbag069
BibTeX
@article{Fanshawe2026,
author = {Fanshawe, Jack B and Watson, Cameron J and Mancini, Valentina and Cohen, Matthew and Koçyiğit, Doğukan and Bohra, Rijul and Zauchenberger, Chambrez-Zita and Varvari, Ioana and Farid, Anna and Perez-Rodriguez, Violeta and Gifford, George and Pillinger, Toby and Beck, Katherine and Jauhar, Sameer and McGuire, Philip and McCutcheon, Robert A},
title = {Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysis},
journal = {Schizophrenia Bulletin},
year = {2026},
volume = {52},
number = {3},
doi = {10.1093/schbul/sbag069}
}
EUVIMED